It took almost two months for Moderna to see their vaccine approved for marketing for teenagers between 12 and 17 years old.
In May 2021, Moderna Therapeutics CEO Stéphane Bancel already explained to our peers from Journal du Dimanche “the ideal would be to protect them before late August. If we massively vaccinate, the risk of a fourth wave could be prevented”.
The vaccine is “highly effective” in people from this age group, up to 100%, like for the Pfizer vaccine. The study included over 3,700 volunteers between 12 and 17 years old, split into two groups: two thirds have been given the vaccine, and one third a placebo. Like for the Pfizer vaccine, Moderna vaccine lies in the RNA technology.
As teens are on vacations, the government is thinking about a vaccinal strategy for when school starts, with vaccination performed in schools. The government recently announced the health pass will not be compulsory to enter junior high schools or high schools.